anti-MESO CAR-T cells (Zhejiang University)

N/A

Report date: 2024/11/22 20:00:28

Base Information

Drug Nameanti-MESO CAR-T cells (Zhejiang University)
Drug Alias NameUCLM802 Cell Injection(Zhejiang University)Anti-mesothelin CAR-T cells(Zhejiang University)UCLM802UCLM-802
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyCell and gene therapy > Gene therapy
Mechanisms of ActionMesothelin inhibitors
TargetsMesothelin
Therapy Area/IndicationsSolid tumoursOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesZhejiang UniversityHrain Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang University
Inactive CompaniesSecond Affiliated Hospital School Of Zhejiang University School Of MedicineHrain Biotechnology Co Ltd
Active IndicationsSolid tumours
Inactive IndicationsOvarian Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A